Literature DB >> 11689658

Amino acids responsible for the absolute sialidase activity of the influenza A virus neuraminidase: relationship to growth in the duck intestine.

D Kobasa1, K Wells, Y Kawaoka.   

Abstract

The 1957 human pandemic strain of influenza A virus contained an avian virus hemagglutinin (HA) and neuraminidase (NA), both of which acquired specificity for the human receptor, N-acetylneuraminic acid linked to galactose of cellular glycoconjugates via an alpha2-6 bond (NeuAcalpha2-6Gal). Although the NA retained considerable specificity for NeuAcalpha2-3Gal, its original substrate in ducks, it lost the ability to support viral growth in the duck intestine, suggesting a growth-restrictive change other than a shift in substrate specificity. To test this possibility, we generated a panel of reassortant viruses that expressed the NA genes of human H2N2 viruses isolated from 1957 to 1968 with all other genes from the avian virus A/duck/Hong Kong/278/78 (H9N2). Only the NA of A/Singapore/1/57 supported efficient viral growth in the intestines of orally inoculated ducks. The growth-supporting capacity of the NA correlated with a high level of enzymatic activity, comparable to that found to be associated with avian virus NAs. The specific activities of the A/Ann Arbor/6/60 and A/England/12/62 NAs, which showed greatly restricted abilities to support viral growth in ducks, were only 8 and 5%, respectively, of the NA specific activity for A/Singapore/1/57. Using chimeric constructs based on A/Singapore/1/57 and A/England/12/62 NAs, we localized the determinants of high specific NA activity to a region containing six amino acid substitutions in A/England/12/62: Ser331-->Arg, Asp339-->Asn, Asn367-->Ser, Ser370-->Leu, Asn400-->Ser, and Pro431-->Glu. Five of these six residues (excluding Asn400) were required and sufficient for the full specific activity of the A/Singapore/1/57 NA. Thus, in addition to a change in substrate specificity, a reduction in high specific activity may be required for the adaptation of avian virus NAs to growth in humans. This change is likely needed to maintain an optimal balance between NA activity and the lower affinity shown by human virus HAs for their cellular receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689658      PMCID: PMC114763          DOI: 10.1128/JVI.75.23.11773-11780.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Antigenic structure and variation in an influenza virus N9 neuraminidase.

Authors:  R G Webster; G M Air; D W Metzger; P M Colman; J N Varghese; A T Baker; W G Laver
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

2.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Authors:  P Palese; K Tobita; M Ueda; R W Compans
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

3.  Antigenic hybrids of influenza A viruses with surface antigens to order.

Authors:  R G Webster
Journal:  Virology       Date:  1970-11       Impact factor: 3.616

4.  Altered tissue tropism of human-avian reassortant influenza viruses.

Authors:  V S Hinshaw; R G Webster; C W Naeve; B R Murphy
Journal:  Virology       Date:  1983-07-15       Impact factor: 3.616

5.  On the origin of the human influenza virus subtypes H2N2 and H3N2.

Authors:  C Scholtissek; W Rohde; V Von Hoyningen; R Rott
Journal:  Virology       Date:  1978-06-01       Impact factor: 3.616

6.  Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice.

Authors:  M T Hughes; M Matrosovich; M E Rodgers; M McGregor; Y Kawaoka
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2,3 linkage is associated with intestinal replication of influenza A virus in ducks.

Authors:  T Ito; Y Suzuki; T Suzuki; A Takada; T Horimoto; K Wells; H Kida; K Otsuki; M Kiso; H Ishida; Y Kawaoka
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.

Authors:  L J Mitnaul; M N Matrosovich; M R Castrucci; A B Tuzikov; N V Bovin; D Kobasa; Y Kawaoka
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  Influenza virus neuraminidase with hemagglutinin activity.

Authors:  W G Laver; P M Colman; R G Webster; V S Hinshaw; G M Air
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

10.  Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.

Authors:  G N Rogers; J C Paulson
Journal:  Virology       Date:  1983-06       Impact factor: 3.616

View more
  25 in total

1.  Substrate specificity of avian influenza H5N1 neuraminidase.

Authors:  Naruthai Onsirisakul; Shin-Ichi Nakakita; Chompunuch Boonarkart; Alita Kongchanagul; Ornpreya Suptawiwat; Pilaipan Puthavathana; Krisada Chaichuen; Kanokwan Kittiniyom; Yasuo Suzuki; Prasert Auewarakul
Journal:  World J Virol       Date:  2014-11-12

2.  Influenza virus neuraminidase contributes to secondary bacterial pneumonia.

Authors:  Ville T Peltola; K Gopal Murti; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2005-06-08       Impact factor: 5.226

3.  Allele-specific nonstationarity in evolution of influenza A virus surface proteins.

Authors:  Anfisa V Popova; Ksenia R Safina; Vasily V Ptushenko; Anastasia V Stolyarova; Alexander V Favorov; Alexey D Neverov; Georgii A Bazykin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-02       Impact factor: 11.205

4.  Sequence and phylogenetic analysis of neuraminidase genes of H9N2 avian influenza viruses isolated from commercial broiler chicken in Iran (2008 and 2009).

Authors:  Masoud Soltanialvar; Hamid Shoushtari; Mohamadhasan Bozorgmehrifard; Saeed Charkhkar; Farshad Akbarnejad
Journal:  Trop Anim Health Prod       Date:  2011-07-09       Impact factor: 1.559

5.  The Low-pH Resistance of Neuraminidase Is Essential for the Replication of Influenza A Virus in Duck Intestine following Infection via the Oral Route.

Authors:  Yoshikazu Fujimoto; Hiroshi Ito; Etsuro Ono; Yoshihiro Kawaoka; Toshihiro Ito
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

6.  Adjustment of receptor-binding and neuraminidase substrate specificities in avian-human reassortant influenza viruses.

Authors:  Yulia Shtyrya; Larisa Mochalova; Galina Voznova; Irina Rudneva; Aleksandr Shilov; Nikolai Kaverin; Nicolai Bovin
Journal:  Glycoconj J       Date:  2008-07-26       Impact factor: 2.916

7.  Neuraminidase and hemagglutinin matching patterns of a highly pathogenic avian and two pandemic H1N1 influenza A viruses.

Authors:  Yonghui Zhang; Xiaojing Lin; Guoqin Wang; Jianfang Zhou; Jian Lu; Honglan Zhao; Fengwei Zhang; Jia Wu; Chunqiong Xu; Ning Du; Zi Li; Ye Zhang; Xiaoyi Wang; Shengli Bi; Yuelong Shu; Hongning Zhou; Wenjie Tan; Xiaobing Wu; Zhihui Chen; Yue Wang
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

8.  Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human population.

Authors:  Azeem M Butt; Samerene Siddique; Muhammad Idrees; Yigang Tong
Journal:  Virol J       Date:  2010-11-15       Impact factor: 4.099

9.  Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host.

Authors:  Emmie de Wit; Vincent J Munster; Debby van Riel; Walter E P Beyer; Guus F Rimmelzwaan; Thijs Kuiken; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

10.  Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.

Authors:  Hui-Ling Yen; Natalia A Ilyushina; Rachelle Salomon; Erich Hoffmann; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.